Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Long-Term Debt : ¥137.5 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shanxi C&Y Pharmaceutical Group Co Long-Term Debt?

Shanxi C&Y Pharmaceutical Group Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥137.5 Mil.

Shanxi C&Y Pharmaceutical Group Co's quarterly Long-Term Debt increased from Sep. 2023 (¥128.8 Mil) to Dec. 2023 (¥139.9 Mil) but then declined from Dec. 2023 (¥139.9 Mil) to Mar. 2024 (¥137.5 Mil).

Shanxi C&Y Pharmaceutical Group Co's annual Long-Term Debt increased from Dec. 2021 (¥33.0 Mil) to Dec. 2022 (¥174.5 Mil) but then declined from Dec. 2022 (¥174.5 Mil) to Dec. 2023 (¥139.9 Mil).

Shanxi C&Y Pharmaceutical Group Co Long-Term Debt Historical Data

The historical data trend for Shanxi C&Y Pharmaceutical Group Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi C&Y Pharmaceutical Group Co Long-Term Debt Chart

Shanxi C&Y Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

190.08

106.56

33.04

174.52

139.90

Shanxi C&Y Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															167.52	159.26	128.76	139.90	137.50

Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Shanxi C&Y Pharmaceutical Group Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Shanxi C&Y Pharmaceutical Group Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi C&Y Pharmaceutical Group Co Ltd (SZSE:300254) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

No.53, Hubin Street, Economic and Technological Development Zone, Datong, CHN, 037010

Website

http://www.cy-pharm.com

Shanxi C&Y Pharmaceutical Group Co Ltd is engaged in the production, research and development, and sales of pharmaceutical products. The company offers pregnancy products and services, anti-infective, and urinary health.

Executives

Zuo Xue Min	Supervisors
Huang Le Qun	Director
Zhang Zhen Biao	Executives
Yu Jun Xian	Directors, Directors, and Executives
Zhao Qun	Director
Weng Zhan Guo	Director
Geng Chun Feng	Director
Pang Xiao Quan	Supervisors
Zhong Hai Rong	Directors, executives
Xuan Hang	Director

Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Headlines

No Headlines